Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Injectable Anticoagulants Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Injectable Anticoagulants Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Low-molecular-weight Heparin (LMWH)
1.3.3 Direct Thrombin Inhibitor (DTI)
1.3.4 Other
1.4 Market Segment by Application
1.4.1 Global Injectable Anticoagulants Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 VTE
1.4.3 ACS/MI
1.4.4 AF
1.4.5 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.1 Global Injectable Anticoagulants Revenue (2015-2026)
2.1.2 Global Injectable Anticoagulants Sales (2015-2026)
2.2 Injectable Anticoagulants Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Injectable Anticoagulants Sales by Regions (2015-2020)
2.2.2 Global Injectable Anticoagulants Revenue by Regions (2015-2020)
2.3 Global Top Injectable Anticoagulants Regions (Countries) Ranking by Market Size
2.4 Injectable Anticoagulants Industry Trends
2.4.1 Injectable Anticoagulants Market Top Trends
2.4.2 Market Drivers
2.4.3 Injectable Anticoagulants Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Injectable Anticoagulants Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Injectable Anticoagulants Manufacturers by Sales (2015-2020)
3.1.1 Global Injectable Anticoagulants Sales by Manufacturers (2015-2020)
3.1.2 Global Injectable Anticoagulants Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Injectable Anticoagulants Sales in 2019
3.2 Global Top Manufacturers Injectable Anticoagulants by Revenue
3.2.1 Global Injectable Anticoagulants Revenue by Manufacturers (2015-2020)
3.2.2 Global Injectable Anticoagulants Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Injectable Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2019)
3.4 Global Injectable Anticoagulants Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Injectable Anticoagulants Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Injectable Anticoagulants Market
3.7 Key Manufacturers Injectable Anticoagulants Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Injectable Anticoagulants Historic Market Review by Type (2015-2020)
4.1.2 Global Injectable Anticoagulants Sales Market Share by Type (2015-2020)
4.1.3 Global Injectable Anticoagulants Revenue Market Share by Type (2015-2020)
4.1.4 Injectable Anticoagulants Price by Type (2015-2020)
4.1 Global Injectable Anticoagulants Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Injectable Anticoagulants Sales Forecast by Type (2021-2026)
4.2.3 Global Injectable Anticoagulants Revenue Forecast by Type (2021-2026)
4.2.4 Injectable Anticoagulants Price Forecast by Type (2021-2026)
5 Global Injectable Anticoagulants Market Size by Application
5.1 Global Injectable Anticoagulants Historic Market Review by Application (2015-2020)
5.1.2 Global Injectable Anticoagulants Sales Market Share by Application (2015-2020)
5.1.3 Global Injectable Anticoagulants Revenue Market Share by Application (2015-2020)
5.1.4 Injectable Anticoagulants Price by Application (2015-2020)
5.2 Global Injectable Anticoagulants Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Injectable Anticoagulants Sales Forecast by Application (2021-2026)
5.2.3 Global Injectable Anticoagulants Revenue Forecast by Application (2021-2026)
5.2.4 Injectable Anticoagulants Price Forecast by Application (2021-2026)
6 North America
6.1 North America Injectable Anticoagulants Breakdown Data by Company
6.2 North America Injectable Anticoagulants Breakdown Data by Type
6.3 North America Injectable Anticoagulants Breakdown Data by Application
6.4 North America Injectable Anticoagulants Breakdown Data by Countries
6.4.1 North America Injectable Anticoagulants Sales by Countries
6.4.2 North America Injectable Anticoagulants Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Injectable Anticoagulants Breakdown Data by Company
7.2 Europe Injectable Anticoagulants Breakdown Data by Type
7.3 Europe Injectable Anticoagulants Breakdown Data by Application
7.4 Europe Injectable Anticoagulants Breakdown Data by Countries
7.4.1 Europe Injectable Anticoagulants Sales by Countries
7.4.2 Europe Injectable Anticoagulants Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Injectable Anticoagulants Breakdown Data by Company
8.2 Asia Pacific Injectable Anticoagulants Breakdown Data by Type
8.3 Asia Pacific Injectable Anticoagulants Breakdown Data by Application
8.4 Asia Pacific Injectable Anticoagulants Breakdown Data by Regions
8.4.1 Asia Pacific Injectable Anticoagulants Sales by Regions
8.4.2 Asia Pacific Injectable Anticoagulants Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Injectable Anticoagulants Breakdown Data by Company
9.2 Latin America Injectable Anticoagulants Breakdown Data by Type
9.3 Latin America Injectable Anticoagulants Breakdown Data by Application
9.4 Latin America Injectable Anticoagulants Breakdown Data by Countries
9.4.1 Latin America Injectable Anticoagulants Sales by Countries
9.4.2 Latin America Injectable Anticoagulants Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Injectable Anticoagulants Breakdown Data by Type
10.2 Middle East and Africa Injectable Anticoagulants Breakdown Data by Application
10.3 Middle East and Africa Injectable Anticoagulants Breakdown Data by Countries
10.3.1 Middle East and Africa Injectable Anticoagulants Sales by Countries
10.3.2 Middle East and Africa Injectable Anticoagulants Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Corporation Information
11.1.2 Sanofi Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Sanofi Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Sanofi Injectable Anticoagulants Products and Services
11.1.5 Sanofi SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Genentech (Roche)
11.2.1 Genentech (Roche) Corporation Information
11.2.2 Genentech (Roche) Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Genentech (Roche) Injectable Anticoagulants Products and Services
11.2.5 Genentech (Roche) SWOT Analysis
11.2.6 Genentech (Roche) Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Corporation Information
11.3.2 Boehringer Ingelheim Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Boehringer Ingelheim Injectable Anticoagulants Products and Services
11.3.5 Boehringer Ingelheim SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Injectable Anticoagulants Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Corporation Information
11.5.2 The Medicines Company Business Overview and Total Revenue (2019 VS 2018)
11.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 The Medicines Company Injectable Anticoagulants Products and Services
11.5.5 The Medicines Company SWOT Analysis
11.5.6 The Medicines Company Recent Developments
11.6 Aspen
11.6.1 Aspen Corporation Information
11.6.2 Aspen Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Aspen Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Aspen Injectable Anticoagulants Products and Services
11.6.5 Aspen SWOT Analysis
11.6.6 Aspen Recent Developments
11.7 Otsuka
11.7.1 Otsuka Corporation Information
11.7.2 Otsuka Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Otsuka Injectable Anticoagulants Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Otsuka Injectable Anticoagulants Products and Services
11.7.5 Otsuka SWOT Analysis
11.7.6 Otsuka Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Injectable Anticoagulants Sales Channels
12.2.2 Injectable Anticoagulants Distributors
12.3 Injectable Anticoagulants Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Injectable Anticoagulants Sales Forecast (2021-2026)
13.1.1 Global Injectable Anticoagulants Sales Forecast by Regions (2021-2026)
13.1.2 Global Injectable Anticoagulants Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Injectable Anticoagulants Sales Forecast (2021-2026)
13.2.2 North America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.2.3 North America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Injectable Anticoagulants Sales Forecast (2021-2026)
13.3.2 Europe Injectable Anticoagulants Revenue Forecast (2021-2026)
13.3.3 Europe Injectable Anticoagulants Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Injectable Anticoagulants Sales Forecast (2021-2026)
13.4.2 Asia Pacific Injectable Anticoagulants Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Injectable Anticoagulants Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Injectable Anticoagulants Sales Forecast (2021-2026)
13.5.2 Latin America Injectable Anticoagulants Revenue Forecast (2021-2026)
13.5.3 Latin America Injectable Anticoagulants Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Injectable Anticoagulants Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Injectable Anticoagulants Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Injectable Anticoagulants Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Sanofi、Genentech (Roche)、Boehringer Ingelheim、Pfizer、The Medicines Company、Aspen、Otsuka
【免責事項】
https://www.globalresearch.jp/disclaimer